IDK® Myeloperoxidase ELISA

Article number: K 6631B



Pack size

96 Tests

Standard concentrations included in the kit

1.9-30 ng/ml

Possible sample matrix and volumes

Plasma 100 µl
Serum 25 µl

Incubation periods

  1. 1 hour
  2. 1 hour
  3. 10-20 minutes


Regulatory Status

CE marked

MPO as prognostic marker for cardiovascular diseases
MPO is part of the defense mechanism of the polymorphonuclear leukocytes against exogenic substances. Recent studies suggest a mechanistic link between myeloperoxidase, inflammation and both acute and chronic manifestations of cardiovascular diseases.

MPO is suited for the followin indications:

  • Oxidative stress
  • Risk asssessment in patients with acute coronary syndrome